Literature DB >> 12847038

Rising to the challenge: transforming the treatment of ST-segment elevation myocardial infarction.

William A Ghali1, Cameron R Donaldson, Merril L Knudtson, Steven J Lewis, Colleen J Maxwell, Jack V Tu.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12847038      PMCID： PMC164941     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  20 in total

Review 1.  Prehospital thrombolysis in acute myocardial infarction.

Authors:  H R Arntz
Journal:  Thromb Res       Date:  2001-09-30       Impact factor: 3.944

2.  Technological change around the world: evidence from heart attack care.

Authors: 
Journal:  Health Aff (Millwood)       Date:  2001 May-Jun       Impact factor: 6.301

3.  New advances in the management of acute coronary syndromes: 1. Matching treatment to risk.

Authors:  D Fitchett; S Goodman; A Langer
Journal:  CMAJ       Date:  2001-05-01       Impact factor: 8.262

4.  Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study.

Authors:  F Vermeer; A J Oude Ophuis; E J vd Berg; L G Brunninkhuis; C J Werter; A G Boehmer; A H Lousberg; W R Dassen; F W Bär
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

Review 5.  Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction.

Authors:  M Cucherat; E Bonnefoy; G Tremeau
Journal:  Cochrane Database Syst Rev       Date:  2000

6.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.

Authors:  W D Weaver; R J Simes; A Betriu; C L Grines; F Zijlstra; E Garcia; L Grinfeld; R J Gibbons; E E Ribeiro; M A DeWood; F Ribichini
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

7.  Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent.

Authors:  C Loubeyre; T Lefèvre; Y Louvard; P Dumas; J F Piéchaud; J J Lanore; J F Angellier; J Y Le Tarnec; G Karrillon; A Margenet; C Pougès; M C Morice
Journal:  Eur Heart J       Date:  2001-07       Impact factor: 29.983

8.  Trends in treatment and outcomes for acute myocardial infarction: 1975-1995.

Authors:  P A Heidenreich; M McClellan
Journal:  Am J Med       Date:  2001-02-15       Impact factor: 4.965

9.  Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators.

Authors:  G W Stone; C L Grines; D Rothbaum; K F Browne; J O'Keefe; P A Overlie; B C Donohue; N Chelliah; R Vlietstra; T Catlin; W W O'Neill
Journal:  J Am Coll Cardiol       Date:  1997-04       Impact factor: 24.094

Review 10.  Cost and quality of life: thrombolysis and primary angioplasty.

Authors:  L Goldman
Journal:  J Am Coll Cardiol       Date:  1995-06       Impact factor: 24.094
View more
  6 in total

1.  CYPHER coronary stents and risk of thrombosis.

Authors:  Stephen B Choi
Journal:  CMAJ       Date:  2003-08-05       Impact factor: 8.262

Review 2.  Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit.

Authors:  Paul W Armstrong; Robert C Welsh
Journal:  CMAJ       Date:  2003-10-28       Impact factor: 8.262

Review 3.  Delivery of primary percutaneous coronary intervention for the management of acute ST segment elevation myocardial infarction: summary of the Cardiac Care Network of Ontario Consensus Report.

Authors:  Marino Labinaz; Terri Swabey; Randal Watson; Madhu Natarajan; Wendy Fucile; Bruce Lubelsky; Bruce Sawadsky; Eric Cohen; Kevin Glasgow
Journal:  Can J Cardiol       Date:  2006-03-01       Impact factor: 5.223

4.  A survey of primary percutaneous coronary intervention for patients with ST segment elevation myocardial infarction in Canadian hospitals.

Authors:  Dennis T Ko; Linda R Donovan; Thao Huynh; Stéphane Rinfret; Derek Y So; Michael P Love; Diane Galbraith; Jack V Tu
Journal:  Can J Cardiol       Date:  2008-11       Impact factor: 5.223

5.  Effects of atorvastatin and ticagrelor combination therapy on renal function and the levels of suppression of tumorigenicity 2 and interleukin-33 in patients with ST-segment elevation myocardial infarction.

Authors:  Li Zhang; Miao Hu; Yuan Chen; Yijun Wang
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

6.  Determining geographic areas and populations with timely access to cardiac catheterization facilities for acute myocardial infarction care in Alberta, Canada.

Authors:  Alka B Patel; Nigel M Waters; William A Ghali
Journal:  Int J Health Geogr       Date:  2007-10-16       Impact factor: 3.918
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.